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Introduction 
 
 
The p53 protein is one of the best-known tumor suppressors. Its mutations 
can be found in many different types of tumors (colon, lung, breast, oesophagus, liver, 
urinary bladder, ovaries, brain). Many times the main reason of tumor formation is not 
the presence of mutations in the p53 sequence, but the flaws in the p53-activating 
pathways. Activated p53 is able to inhibit the cell cycle, bring about apoptosis, and 
plays a vital role in the induction of cell differentiation. It is also well-known that wild 
type p53 inhibits angiogenesis in tumors by regulating genes involved in forming 
blood vessels. The cell cycle inhibiting function of p53 is achieved through its activity 
as a transcription factor and the protein is able to activate numerous apoptotic genes 
too. 
 
 
Aims 
 
 
The Drosophila melanogaster orthologue of human p53 was identified 
approximately at the same time by three American laboratories. Although the amino 
acid sequences of human p53 and Dmp53 are just partly identical they do bear 
numerous similar functions. This indicates that numerous p53-related biochemical 
pathways are conserved and it is sensible to study the functions of the protein in detail 
using the well-known model organism Drosophila melanogaster. Since p53 is a really 
important protein, all piece of information about it can be very interesting. Fly fruit - 
as an excellent multicellular model organism - offers a great possibility for the 
detailed biochemical and genetic observation of p53. 
In order to clarify the role of p53 in flies I identified Dmp53-interacting 
partners by carrying out a yeast two-hybrid screen using a Drosophila cDNA library. 
Enzymes that play roles in the posttranslational modification called sumoylation were 
found to interact with Dmp53. 
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 I wanted to identify which regions of Dmp53 interact with the DmUba2 
(SUMO-activating enzyme), DmUbc9 (SUMO-conjugating enzyme) and DmPias 
(SUMO-ligase).    
 I investigated the genetic interactions between Dmp53 and the genes 
encoding the sumoylation enzymes. 
 Finally, my aim was to investigate the effects of the mutation altering the 
sumoylation site on the in vivo function of the protein. 
 
 
Methods and Materials 
 
In vitro recombinant DNS techniques 
Nucleic acid preparation 
Polymerase chain reaction, quantitative reverse transcription-coupled PCR 
Northern analysis 
Western analysis 
Immunoprecipitation 
Yeast two-hybrid experiments 
GST-pulldown 
Establishment of transgenic Drosophila melanogaster lines with P-element insertion 
and φC31 transgene integration system   
In vivo functional studies with the UAS-GAL4 system 
LOH assay 
Staining of Drosophila larval tissues 
Handling and transformation of Drosophila S2 cell culture 
Measurement of luciferase activity 
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Results 
 
 
1. The C-terminus of Dmp53 interacts with the sumoylation enzymes 
 By using yeast two-hybrid the C-terminus of Dmp53 was found to interact 
with the sumoylation enzymes. The C-terminus of the protein can be split functionally 
into two parts: oligomerization domain and basic domain. DmUba2 interacts with the 
basic domain of Dmp53, DmUbc9 interacts with both the oligomerization domain and 
basic domain. The full-length C-terminal fragment is required for the interaction with 
DmPias. The results of the yeast two-hybrid assays were verified by GST-pulldown. 
Only one site was found in the Dmp53 sequence that was fully identical to a 
consensus sumoylation site. The mutation of this site did not abolish the interactions 
between Dmp53 and the sumoylation enzymes. 
 
2.  Partial loss of sumoylating activity decreased the DNA repair activity of 
Dmp53 
 I tried to identify genetic interactions between Dmp53 and the sumoylation 
enzymes. In flies LOH assays are an established means of demonstrating the role 
played by Dmp53 in preserving genome stability. I carried out LOH assays based on 
detection of the recessive multiple wing hairs (Mwh) phenotype caused by the loss of 
the wild-type copy of mwh. To answer whether the decrease of the sumoylation 
activity has any effect on the mutator phenotype of Dmp53 I used LOH assays. I 
generated flies simultaneously heterozygous for Dmp53, for the marker gene mwh, 
and for genes involved in sumoylation: Su(var)2-10, lwr, smt3 or for both lwr and 
smt3. The homozygous mwh clones were counted on the wings of the adults. I found 
that partial loss of Su(var)2-10, lwr or smt3 increased the number of wing clones. 
Thus, I concluded that partial loss of sumoylating activity enhanced the mutator 
phenotype of Dmp53 suggesting that the decreased level of sumoylation may decrease 
the DNA repair activity of Dmp53. 
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3. Decreased sumoylation activity does not have any effects on the overexpression 
of Dmp53 in eyes 
 I examined the effect of decreased sumoylation activity on the 
overexpression of Dmp53 in eyes as well. I found that one copy of either Su(var)2-10/ 
lwr/smt3/lwr-smt3 causes phenotypes in eyes similar to two copies. 
 
4. Overexpression of Dmp53 in Drosophila causes severe phenotypes, and flies 
overexpressing the Dmp53K302R protein die earlier than flies overexpressing 
Dmp53 
 For further study of Dmp53 I generated transgenic flies using P-element 
based techniques. I addressed the question whether overexpression of wild type or 
mutant Dmp53 causes any phenotypic differences. Using the UAS-GAL4 system I 
applied general and tissue-specific drivers to express the transgenes and analyzed the 
phenotypes. I used two strains overexpressing the Dmp53K302R protein on the 2nd or the 
3rd chromosome. Using either the 2nd or the 3rd chromosomal Dmp53-overexpressing 
strains I found that overproduction of the Dmp53K302R protein causes more severe 
phenotypes than that of the wild type overexpressers. The phenotypes are stronger if 
general drivers are used. Interestingly, the phenotypes are stronger in males than in 
females. I generated Dmp53-overexpressing strains in which the transgenes are 
inserted into the same region of the 2nd or 3rd chromosome. In case the transgenes are 
inserted in this site-specific manner there is a smaller difference between the 
phenotypes caused by the overexpression of wild-type and mutant Dmp53 proteins. 
 We raised the question whether the stronger phenotypes are caused by the 
higher protein levels. In order to clarify this question I generated flies that carry two 
copies of the wild-type Dmp53-overexpressing transgene. With the overexpression of 
protein I found that more protein results in stronger phenotypes that are similar to that 
of the Dmp53K302R overexpressers. In accord with this, the simultaneous 
overproduction of Dmp53K302R and a dominant-negative form of Dmp53 (Dmp53H159N) 
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resulted in weaker phenotypes similarly to the wild-type Dmp53 overexpressers. 
These experiments show that the strength of the phenotypes are mainly determined by 
the Dmp53 levels. 
 
5. K302R mutation stabilizes Dmp53 
 I used Western analysis to determine the amount of Dmp53 protein. I found 
that the protein is stabilized in the randomly inserted Dmp53K302R-overexpressing flies 
and reach higher levels compared to the wild type Dmp53 overexpressers. I tried to 
detect SUMO-modified Dmp53 using the same samples but I was not able to detect 
higher migrating forms of the protein. In case of the overproduction of the mutant or 
wild type Dmp53 in the site-specific insertion containing strains I detected 
approximately similar levels of the proteins. 
 In the random insertion containing strains I determined the amount of gene 
products by Northern blot and Q-PCR. Similar levels of mRNA can be detected in the 
mutant and wild type Dmp53-overexpressing strains. On the basis of these 
experiments I concluded that Dmp53 protein is stabilized in Dmp53K302R-
overproducing flies and causes stronger phenotypes than that of wild type 
overexpressers. 
 
6. SUMO modification of Dmp53 cannot be detected in protein samples either 
from flies or from S2 cells  
 A generally used method for the detection of sumoylation is using transfected 
cells. Wild type and mutant Dmp53 were transiently overexpressed in S2 cells and cell 
extracts prepared from these samples were analyzed by immunoblot. I was not able to 
detect any SUMO-modified form of Dmp53, however the overexpression of the 
proteins was successful. Immunoprecipitations were also carried out by using higher 
amount of S2 cells, but no sumoylated Dmp53 was detected, although these 
experiments were repeated several times. Cotransfection experiments were also 
performed in which Dmp53 and SUMO were overproduced simultaneously. No 
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modified Dmp53 forms were detected, although these methods are wide-spread for 
investigating posttranslational modifications of proteins. 
 
7. Dmp53 is located in the nucleus and the K302R mutation does not alter its 
cellular localization 
 Sumoylation has numerous well-known biological functions. Many times the 
unmodified and sumoylated forms of proteins are localized in different compartments 
of the cells so the processes of sumoylation/desumoylation are essential for the 
transport of the given protein between the cytoplasm and the nucleus. Immunostained 
Drosophila tissues revealed that both the wild type and the K302R mutant form of the 
protein are localized in the nucleus. This suggests that the transport of Dmp53 is not or 
not exclusively influenced by the SUMO-modification. 
 
8. The K302R mutation does not influence the transcription activation ability of 
Dmp53 
 Another important role of sumoylation is the modification of transcriptional 
activity of the target protein. I examined the transcriptional activating capacity of the 
wild type and K302R mutant Dmp53 by performing luciferase assays using S2 cells. 
No obvious difference was found in the transactivation ability of Dmp53 and 
Dmp53K302R. 
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